Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 56601 - 56625 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Panobinostat	Approved Investigational	RGMA	56963	downregulated	panobinostat results in decreased expression of RGMA mRNA	15q26.1	A21037
Panobinostat	Approved Investigational	RGS5	8490	upregulated	panobinostat results in increased expression of RGS5 mRNA	1q23.3	A21037
Panobinostat	Approved Investigational	RHOB	388	upregulated	panobinostat results in increased expression of RHOB mRNA	2p24.1	A21037
Panobinostat	Approved Investigational	RHOBTB3	22836	upregulated	panobinostat results in increased expression of RHOBTB3 mRNA	5q15	A21037
Panobinostat	Approved Investigational	RIMS1	22999	upregulated	panobinostat results in increased expression of RIMS1 mRNA	6q13	A21037
Panobinostat	Approved Investigational	RIPK4	54101	upregulated	panobinostat results in increased expression of RIPK4 mRNA	21q22.3	A21037
Panobinostat	Approved Investigational	RND3	390	upregulated	panobinostat results in increased expression of RND3 mRNA	2q23.3	A21037
Panobinostat	Approved Investigational	RNF144B	255488	upregulated	panobinostat results in increased expression of RNF144B mRNA	6p22.3	A21037
Panobinostat	Approved Investigational	RNF150	57484	upregulated	panobinostat results in increased expression of RNF150 mRNA	4q31.21	A21037
Panobinostat	Approved Investigational	RNF175	285533	downregulated	panobinostat results in decreased expression of RNF175 mRNA	4q31.3	A21037
Panobinostat	Approved Investigational	RNF182	221687	downregulated	panobinostat results in decreased expression of RNF182 mRNA	6p23	A21037
Panobinostat	Approved Investigational	RNF217	154214	upregulated	panobinostat results in increased expression of RNF217 mRNA	6q22.31	A21037
Panobinostat	Approved Investigational	RNF43	54894	upregulated	panobinostat results in increased expression of RNF43 mRNA	17q23.2	A21037
Panobinostat	Approved Investigational	ROR1	4919	upregulated	panobinostat results in increased expression of ROR1 mRNA	1p31.3	A21037
Panobinostat	Approved Investigational	RPL31	6160	downregulated	panobinostat results in decreased expression of RPL31 mRNA	2q11.2	A21037
Panobinostat	Approved Investigational	RPP25	54913	upregulated	panobinostat results in increased expression of RPP25 mRNA	15q24.2	A21037
Panobinostat	Approved Investigational	RPRM	56475	upregulated	panobinostat results in increased expression of RPRM mRNA	2q23.3	A21037
Panobinostat	Approved Investigational	RPRML	388394	upregulated	panobinostat results in increased expression of RPRML mRNA	17q21.32	A21037
Panobinostat	Approved Investigational	RPS24	6229	upregulated	panobinostat results in increased expression of RPS24 mRNA	10q22.3	A21037
Panobinostat	Approved Investigational	RPS6KA6	27330	downregulated	panobinostat results in decreased expression of RPS6KA6 mRNA	Xq21.1	A21037
Panobinostat	Approved Investigational	RRAGD	58528	downregulated	panobinostat results in decreased expression of RRAGD mRNA	6q15	A21037
Panobinostat	Approved Investigational	RREB1	6239	upregulated	panobinostat results in increased expression of RREB1 mRNA	6p24.3	A21037
Panobinostat	Approved Investigational	RSPO2	340419	downregulated	panobinostat results in decreased expression of RSPO2 mRNA	8q23.1	A21037
Panobinostat	Approved Investigational	RSPO3	84870	upregulated	panobinostat results in increased expression of RSPO3 mRNA	6q22.33	A21037
Panobinostat	Approved Investigational	RTN1	6252	downregulated	panobinostat results in decreased expression of RTN1 mRNA	14q23.1	A21037

Displaying entries 56601 - 56625 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability